{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:08:54Z","timestamp":1777550934294,"version":"3.51.4"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,8]],"date-time":"2014-04-08T00:00:00Z","timestamp":1396915200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0094051","type":"journal-article","created":{"date-parts":[[2014,4,8]],"date-time":"2014-04-08T21:48:09Z","timestamp":1396993689000},"page":"e94051","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Mucosal Vaccination with Recombinant Lactobacillus casei-Displayed CTA1-Conjugated Consensus Matrix Protein-2 (sM2) Induces Broad Protection against Divergent Influenza Subtypes in BALB\/c Mice"],"prefix":"10.1371","volume":"9","author":[{"given":"Mohammed Y. E.","family":"Chowdhury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabuddha","family":"Pathinayake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasanna","family":"Weeratunga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man Ki","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwa-Young","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Pyo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moon-Hee","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul-Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,4,8]]},"reference":[{"key":"ref1","first-page":"43","article-title":"Seasonal influenza vaccines","volume":"333","author":"AE Fiore","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.virusres.2011.09.037","article-title":"Novel vaccines against influenza viruses","volume":"162","author":"SM Kang","year":"2011","journal-title":"Virus Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S0264-410X(01)00471-6","article-title":"Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy A meta-analysis","volume":"20","author":"WEP Beyer","year":"2002","journal-title":"Vaccine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.vaccine.2008.05.076","article-title":"Seasonal inactivated influenza virus vaccines","volume":"26S","author":"RB Couch","year":"2008","journal-title":"Vaccine"},{"key":"ref5","unstructured":"Wright PF, Webster R (2001) Orthomyxoviruses. In: Knipe D.M, Howley PM, editors. Fields Virology: Lippncott Williams &amp; Wilkins Press, Philadelphia. pp. 1533\u20131579."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.vaccine.2007.12.027","article-title":"CTA1-M2e-DD: A novel mucosal adjuvant targeted influenza vaccine","volume":"26","author":"DG Eliasson","year":"2008","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/S0264-410X(99)00005-5","article-title":"Modified M2 proteins produce heterotypic immunity against influenza virus","volume":"17","author":"AM Frace","year":"1999","journal-title":"Vaccine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4161\/hv.3.5.4175","article-title":"Vaxfectin formulated influenza DNA vaccines encodingNP and M2 viral proteins protect mice against lethal viral challenge","volume":"3","author":"GS Jimenez","year":"2007","journal-title":"Hum Vaccin"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1086\/588431","article-title":"Plasmid DNA based vaccines protect mice and ferrets against lethal challenge with A\/Vietnam\/1203\/04 (H5N1) influenza virus","volume":"197","author":"PA Lalor","year":"2008","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3201\/eid1303.061125","article-title":"Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1","volume":"13","author":"SM Tompkins","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1016\/j.vaccine.2007.09.056","article-title":"Characterization of immunity induced by M2e of influenza virus","volume":"25","author":"F Wu","year":"2007","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jps.20493","article-title":"Pharmaceutical and immunological evaluation of human papillomavirus virus like particle as an antigen carrier","volume":"95","author":"RM Ionescu","year":"2006","journal-title":"J Pharm Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vaccine.2007.10.062","article-title":"Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza m2e to the TLR5 ligand flagellin","volume":"26","author":"JW Huleatt","year":"2008","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1743-422X-4-118","article-title":"Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse","volume":"4","author":"K Mozdzanowska","year":"2007","journal-title":"Virol J"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/vim.2013.0013","article-title":"Mucosal Adjuvants for Influenza Virus-Like Particle Vaccine","volume":"26","author":"FS Quan","year":"2013","journal-title":"Viral Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1128\/IAI.63.5.1617-1623.1995","article-title":"Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity","volume":"63","author":"BL Dickinson","year":"1995","journal-title":"Infect Immun"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1128\/JVI.80.8.4079-4087.2006","article-title":"Mucosal immunization with surface displayed severe acute respiratory syndrome coronavirus spike protein on <italic>Lactobacillus casei<\/italic> induces neutralizing antibodies in mice","volume":"80","author":"JS Lee","year":"2006","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1128\/IAI.72.6.3444-3450.2004","article-title":"Mucosal vaccine made from live, recombinant <italic>Lactobacillus lactis<\/italic> protects mice against pharyngeal infection with <italic>Streptococcus pyogenes<\/italic>","volume":"72","author":"P Mannam","year":"2004","journal-title":"Infect Immun"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.virol.2010.08.007","article-title":"Immunoprotection against influenza H5N1 virus by oral administration of eneteric coated recombinant Lactococcus lactis mini-capsules","volume":"407","author":"H Lei","year":"2010","journal-title":"Virology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/76494","article-title":"Surface displayed viral antigens on salmonella carrier vaccine","volume":"18","author":"JS Lee","year":"2000","journal-title":"Nat Biotechnol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"9665","DOI":"10.1128\/JVI.75.20.9665-9670.2001","article-title":"Vaccination with a <italic>Shigella<\/italic> DNA vaccine vector induces antigen-specific CD8<sup>+<\/sup> T cells and antiviral protective immunity","volume":"75","author":"MT Shata","year":"2001","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1046\/j.1365-2567.2000.00069.x","article-title":"Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of the tetanus toxin fragment C-expressing lactobacilli","volume":"100","author":"DM Shaw","year":"2000","journal-title":"Immunology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1182\/blood-2003-01-0110","article-title":"Immunogenecity and protective efficacy of oral administered recombinant <italic>Lactobacillus lactis<\/italic> expressing surface bound HIV Env","volume":"102","author":"KQ Xin","year":"2003","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/AEM.72.1.269-275.2006","article-title":"Display of a-amylase on the surface of <italic>lactobacillus casei<\/italic> cells by use of the PgsA anchor protein, and production of lactic acid from starch","volume":"72","author":"J Narita","year":"2006","journal-title":"Appl Environ Microbiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1365-2958.2006.05179.x","article-title":"Poly-gamma-glutamate in bacteria","volume":"60","author":"T Candela","year":"2006","journal-title":"Mol Microbiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/ijc.22035","article-title":"Oral administration of human papillomavirus type 16 E7 displayed on <italic>Lactobacillus casei<\/italic> induces E7-specific antitumor effects in C57\/BL6 mice","volume":"119","author":"H Poo","year":"2006","journal-title":"Int J Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1007\/s00253-011-3734-0","article-title":"High-level mucosal and systemic immune responses induced by oral administration with <italic>Lactobacillus-<\/italic>expressed porcine epidemic diarrhea virus (PEDV) S1 region combined with <italic>Lactobacillus-<\/italic>expressed N protein","volume":"93","author":"LD Qiu","year":"2012","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1128\/JB.183.14.4157-4166.2001","article-title":"Design of protein-targeting system for lactic acid bacteria","volume":"183","author":"Y Dieye","year":"2001","journal-title":"J Bacteriol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00705-010-0621-4","article-title":"Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant","volume":"155","author":"Z Sui","year":"2010","journal-title":"Arch Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e27953","DOI":"10.1371\/journal.pone.0027953","article-title":"Sublingual Immunization with M2-Based Vaccine Induces Broad Protective Immunity against Influenza","volume":"6","author":"BS Shim","year":"2011","journal-title":"PLoS ONE"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.4049\/jimmunol.171.4.1999","article-title":"DNA vaccine combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4 producing CD4+ and CD8+ T cells","volume":"171","author":"AE Oran","year":"2003","journal-title":"J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vetmic.2012.05.035","article-title":"Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate\/chitosan nanoparticles induces protection against highly pathogenic influenza A virus","volume":"160","author":"HJ Moon","year":"2012","journal-title":"Vet Microbiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1128\/JVI.02052-06","article-title":"Virus Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Influenza Virus","volume":"81","author":"FS Quan","year":"2007","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1743-422X-7-9","article-title":"An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses","volume":"7","author":"G Zhao","year":"2010","journal-title":"Virol J"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/nature08260","article-title":"In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses","volume":"460","author":"Y Itoh","year":"2009","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1128\/JVI.65.10.5491-5498.1991","article-title":"Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins","volume":"65","author":"T Ito","year":"1991","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virusres.2004.02.030","article-title":"A \u201cuniversal\u201d human influenza A vaccine","volume":"103","author":"W Fiers","year":"2004","journal-title":"Virus Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1073\/pnas.0500098102","article-title":"Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization","volume":"102","author":"M Mohamadzadeh","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.antiviral.2013.06.010","article-title":"Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection","volume":"99","author":"MC Kim","year":"2013","journal-title":"Antiviral Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/S0264-410X(99)00005-5","article-title":"Modified M2 proteins produce heterotypic immunity against influenza A virus","volume":"17","author":"AM Frace","year":"1999","journal-title":"Vaccine"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4161\/hv.5.4.7553","article-title":"<italic>Lactococcus lactis<\/italic> as a live vector for mucosal delivery of therapeutic proteins","volume":"504","author":"LG Bermu\u2032dez-Humara\u2032n","year":"2009","journal-title":"Hum Vaccin"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.mib.2013.06.002","article-title":"Engineering lactococci and lactobacilli for human health","volume":"16","author":"LG Berm\u00fadez-Humar\u00e1n","year":"2013","journal-title":"Curr Opin Microbiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1440-1711.1998.00750.x","article-title":"A novel concept in mucosal adjuvanticity: The CTA1-DD adjuvant is a B cell-targeted fusion protein that incorporates the enzymatically active cholera toxin A1 subunit","volume":"76","author":"L Agren","year":"1998","journal-title":"Immunol Cell Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.vaccine.2005.08.061","article-title":"The universal influenza vaccine M2e-HBc administered intranasally in combination with the adjuvant CTA1-DD provides complete protection","volume":"24","author":"M De Filette","year":"2006","journal-title":"Vaccine"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.4049\/jimmunol.173.5.3310","article-title":"The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues","volume":"173","author":"AM Eriksson","year":"2004","journal-title":"J Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"J Sui","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"ref47","unstructured":"Song MK (2010) A1 moiety of cholera toxin A subunit as an adjuvant for mucosal and systemic vaccines. World Intellectual Property Organization patent WO2010046783."},{"key":"ref48","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1128\/CVI.05618-11","article-title":"Mucosal and Systemic Immune Responses Induced by Recombinant Lactobacillus spp. Expressing the Hemagglutinin of the Avian Influenza Virus H5N1","volume":"19","author":"Z Wang","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2008.06.002","article-title":"Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein","volume":"80","author":"R Wang","year":"2008","journal-title":"Antiviral Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.virol.2008.11.035","article-title":"Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus","volume":"385","author":"TM Fu","year":"2009","journal-title":"Virology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"A Jegerlehner","year":"2004","journal-title":"J Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1016\/j.vaccine.2009.04.075","article-title":"The co-administration of CpG-ODN influenced protective activity of influenza M2e vaccine","volume":"27","author":"F Wu","year":"2009","journal-title":"Vaccine"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1016\/j.vaccine.2009.08.053","article-title":"Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses","volume":"27","author":"GE Price","year":"2009","journal-title":"Vaccine"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e14538","DOI":"10.1371\/journal.pone.0014538","article-title":"Influenza Virus-Like particles containing M2 induce broadly cross protective immunity","volume":"6","author":"JM Song","year":"2011","journal-title":"PLoS One"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection","volume":"186","author":"KEl Bakkouri","year":"2011","journal-title":"J Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.intimp.2004.12.005","article-title":"The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection","volume":"5","author":"P Zou","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"e5538","DOI":"10.1371\/journal.pone.0005538","article-title":"Vaccination against Human Influenza A\/H3N2 Virus Prevents the Induction of Heterosubtypic Immunity against Lethal Infection with Avian Influenza A\/H5N1 Virus","volume":"4","author":"R Bodewes","year":"2009","journal-title":"PLoS ONE"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0094051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T12:54:09Z","timestamp":1597668849000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0094051"}},"subtitle":[],"editor":[{"given":"Stephen Mark","family":"Tompkins","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,8]]},"references-count":57,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0094051","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,8]]}}}